Jack A. Khattar - President, CEO, Director at SUPERNUS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO, Director
Issuer Symbol
SUPN on Nasdaq
All Insider Reports
All Insider Reports

Jack A. Khattar - trading volume in the past year for SUPERNUS PHARMACEUTICALS, INC.

Holdings reported by Jack A. Khattar for SUPERNUS PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,206,578 $62,090,503 $51.46 09 Oct 2025 Direct
Common Stock 1,005,600 $48,057,624 $47.79 09 Oct 2025 By the KBT Trust
Performance Share Unit 0 $0 $32.06 02 Oct 2025 Direct Common Stock
Performance Share Units 0 $0 $39.11 02 Oct 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 0 09 Oct 2025 Direct Common Stock

Transactions reported by Jack A. Khattar for SUPERNUS PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.